[quote name='depascal22']I wasn't trying to insult your intelligence, dmaul. I'm just explaining the process to some of the other people that will come in here and start blowing things up because we're not talking about keeping taxes low and guvmint out of our wallets.
[/quote]
Oh I didn't take it as an insult at all. I was just clarifying what I meant.
I agree on the one hand--it does probably help promote innovation due to the pressure to develop the next break through drug before the competing company. But prices get driven up by the high salaries paid to executives etc. in the drug companies as well, which sucks away some of the money that could go into future R&D.
Vs. a purely academic setting where profs are getting research grants mainly to get publications to earn tenure and promotion and prestige with in the field rather than put money in our pockets. We're pretty limited in how much income we can pay ourselves by grant. Most places it's just paying summer salary (we're 9 month employees) which is usually capped at 30% of your 9 month salary. Then the rest that could be used on yourself would be going to the university in the form of course releases--paying them back for your time so the hire someone else to cover your course so you can devote more time to the research. The rest of the grant goes to supplies, travel (if needed), hiring research assistants etc.
Long-winded point being that money isn't as much of an incentive driving academic research as it is for private research. The main goals are producing knowledge and earning prestige.
The question is which system drives more innovation and puts more resources in to research and developing new drugs (or knowledge in other fields). Private corporations motivated 100% by profit? Or a university setting where research isn't as much driven by profit, and more by the discipline requiring the production of knowledge (and publications of it) for tenure, promotion and prestige?
I don't have the answer, and my opinion is obviously biased. But it's an interesting question in any case.
[/quote]
Oh I didn't take it as an insult at all. I was just clarifying what I meant.
The pharmaceutical industry isn't nearly as bad as the insurance industry though. At least the profits go towards the next drug in the pipeline. So many drugs fail that you need to have a high reward system set up for companies. If you set limits on drug prices, it will stifle innovation in the field.
I agree on the one hand--it does probably help promote innovation due to the pressure to develop the next break through drug before the competing company. But prices get driven up by the high salaries paid to executives etc. in the drug companies as well, which sucks away some of the money that could go into future R&D.
Vs. a purely academic setting where profs are getting research grants mainly to get publications to earn tenure and promotion and prestige with in the field rather than put money in our pockets. We're pretty limited in how much income we can pay ourselves by grant. Most places it's just paying summer salary (we're 9 month employees) which is usually capped at 30% of your 9 month salary. Then the rest that could be used on yourself would be going to the university in the form of course releases--paying them back for your time so the hire someone else to cover your course so you can devote more time to the research. The rest of the grant goes to supplies, travel (if needed), hiring research assistants etc.
Long-winded point being that money isn't as much of an incentive driving academic research as it is for private research. The main goals are producing knowledge and earning prestige.
The question is which system drives more innovation and puts more resources in to research and developing new drugs (or knowledge in other fields). Private corporations motivated 100% by profit? Or a university setting where research isn't as much driven by profit, and more by the discipline requiring the production of knowledge (and publications of it) for tenure, promotion and prestige?
I don't have the answer, and my opinion is obviously biased. But it's an interesting question in any case.